查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1980686

全球心臟瓣膜牽開器市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Cardiac Valvulotome Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計心臟瓣膜牽開器市場將從 2025 年的 1.4556 億美元成長到 2034 年的 2.2368 億美元，2026 年至 2034 年的複合年成長率為 4.89%。

隨著對先進心血管外科手術器械的需求持續旺盛，全球心臟瓣膜牽開器市場正穩定成長。心臟瓣膜牽開器是一種專門用於修復或矯正受損心臟瓣膜的手術器械。心臟病發病率的上升以及對有效手術方式日益成長的需求，都推動了該市場的擴張。

推動市場成長的因素包括心血管疾病發生率上升、人口老化以及外科技術的進步。醫院和醫療機構擴大採用先進的手術器械，以提高手術精度和改善病患預後。此外，發展中地區醫療保健投資的增加和心臟護理服務可近性的提高也促進了市場發展。

展望未來，心臟瓣膜牽開器市場有望受益於醫療技術和外科手術的不斷進步。微創心血管手術日益受到重視以及手術器械的改進將進一步推動市場需求成長。隨著醫療系統持續優先發展心血管疾病的先進治療方法，預計未來幾年該市場將保持穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球心臟瓣膜牽開器市場：按類型分類

  • 市場分析、洞察與預測
  • 可擴張心臟瓣膜牽開器
  • 導絲式心臟瓣膜牽開器

第5章：全球心臟瓣膜牽開器市場：依手術類型分類

  • 市場分析、洞察與預測
  • 瓣膜切開術
  • 二尖瓣交界處
  • 其他（例如，三尖瓣狹窄）

第6章 全球心臟瓣膜牽開器市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 心臟外科中心
  • 門診手術中心
  • 其他（研究機構等）

第7章 全球心臟瓣膜牽開器市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • LeMaitre Vascular Inc
    • Invamed
    • LimFlow Inc
    • B. Braun Melsungen AG
    • Teleflex Incorporated
    • StarFish Medical
    • Koven Technology Inc
    • Becton
    • Dickinson And Company（BD）
    • Symmetry Surgical Inc
    • Andramed GmbH
    • OxSyBio Ltd
簡介目錄
Product Code: VMR112114869

The Cardiac Valvulotome Market size is expected to reach USD 223.68 Million in 2034 from USD 145.56 Million (2025) growing at a CAGR of 4.89% during 2026-2034.

The Global Cardiac Valvulotome Market is growing steadily as the demand for advanced cardiovascular surgical tools continues to rise. Cardiac valvulotomes are specialized medical instruments used during heart valve surgeries to repair or modify damaged valves. The increasing prevalence of heart diseases and the growing need for effective surgical procedures are contributing to the expansion of this market.

Several factors are driving market growth, including the rising incidence of cardiovascular disorders, aging populations, and improvements in surgical techniques. Hospitals and healthcare facilities are increasingly adopting advanced surgical instruments that enhance precision and patient outcomes. Additionally, growing healthcare investments and improved access to cardiac care in developing regions are supporting market development.

Looking forward, the cardiac valvulotome market is expected to benefit from ongoing advancements in medical technology and surgical procedures. The increasing focus on minimally invasive cardiac surgeries and improved surgical instruments will further drive demand. As healthcare systems continue to prioritize advanced treatment options for cardiovascular diseases, the market is projected to experience steady growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Expandable Cardiac Valvulotome
  • Over the Wire Cardiac Valvulotome

By Procedure Type

  • Valvulotomy
  • Mitral Valve Commissurotomy
  • Others (Tricuspid Valve Stenosis, etc.)

By End User

  • Hospitals & Clinics
  • Cardiac Surgery Centers
  • Ambulatory Surgical Centers
  • Others (Research Institutes, etc.)

COMPANIES PROFILED

  • LeMaitre Vascular Inc, Invamed, LimFlow Inc, B Braun Melsungen AG, Teleflex Incorporated, StarFish Medical, Koven Technology Inc, Becton, Dickinson and Company BD, Symmetry Surgical Inc, Andramed GmbH, OxSyBio Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC VALVULOTOME MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Expandable Cardiac Valvulotome Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Over the Wire Cardiac Valvulotome Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC VALVULOTOME MARKET: BY PROCEDURE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Procedure Type
  • 5.2. Valvulotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Mitral Valve Commissurotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others (Tricuspid Valve Stenosis, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC VALVULOTOME MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cardiac Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others (Research Institutes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC VALVULOTOME MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Procedure Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Procedure Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Procedure Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Procedure Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Procedure Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC VALVULOTOME INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 LeMaitre Vascular Inc
    • 9.2.2 Invamed
    • 9.2.3 LimFlow Inc
    • 9.2.4 B. Braun Melsungen AG
    • 9.2.5 Teleflex Incorporated
    • 9.2.6 StarFish Medical
    • 9.2.7 Koven Technology Inc
    • 9.2.8 Becton
    • 9.2.9 Dickinson And Company (BD)
    • 9.2.10 Symmetry Surgical Inc
    • 9.2.11 Andramed GmbH
    • 9.2.12 OxSyBio Ltd